The effect of text reminders on the uptake of type 2 diabetes screening test after gestational diabetes

Reinforcing annual postpartum diabetes screening in women with previous gestational diabetes (REMIND)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN34249419

Enrollment

Registered

2025-11-11

Start date

2026-03-02

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes Nutritional, Metabolic, Endocrine

Interventions

This will be a cluster randomised two-arm parallel-group trial to test the effectiveness of an informational SMS in increasing annual diabetes screening uptake post-partum in women with previous GDM.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: GP practices: 1. Based in England 2. Established for at least a year 3. With at least 5000 registered patients 4. Using the emis web clinical information system

Exclusion criteria

Exclusion criteria: Practices may not enter the study if any of the following apply: 1. Currently using any type of reminder to women with previous GDM to attend annual diabetes screening postpartum 2. Taking part in any other research study or service evaluation exploring the use of reminders to increase the uptake of annual diabetes screening in women with previous GDM

Design outcomes

Primary

Measure	Time frame
Uptake is defined as completion of a diabetes test (HbA1c); Timepoint(s): Control practices: 3 months after randomisation; Intervention practices: 3 months after the second time the SMS has been sent	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

England, United Kingdom

Contacts

Public ContactMoscho Michalopoulou

remindstudy@phc.ox.ac.uk+44 (0)1865 617857

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 4, 2026